Epilepsi tedavisinde kullan\u0131lan antiepileptik ila\u00e7lar\u0131n \u00e7o\u011funun hastada n\u00f6betlerin s\u0131kl\u0131\u011f\u0131n\u0131 ve \u015fiddetini azaltt\u0131\u011f\u0131n\u0131 belirten \u0130stanbul Atlas \u00dcniversitesi T\u0131p Fak\u00fcltesi N\u00f6roloji Anabilim Dal\u0131 Ba\u015fkan\u0131 Prof. Dr. \u00d6zg\u00fcr Bilgin Top\u00e7uo\u011flu, \u201cD\u00fczenli ve do\u011fru dozda kullan\u0131ld\u0131\u011f\u0131nda hastalar\u0131n yakla\u015f\u0131k y\u00fczde 70\u201380\u2019inde n\u00f6betler kontrol alt\u0131na al\u0131nabilir. \u0130la\u00e7lar\u0131n aksat\u0131lmas\u0131 n\u00f6betlerin yeniden ba\u015flamas\u0131na, \u015fiddetlenmesine ve ciddi sa\u011fl\u0131k risklerine yol a\u00e7abilir\u201d dedi. Epilepsi hastalar\u0131nda ila\u00e7 kullan\u0131m\u0131n\u0131n tedavinin en kritik par\u00e7as\u0131 oldu\u011funu vurgulayan Bilgin Top\u00e7uo\u011flu, ila\u00e7lar\u0131n do\u011fru \u015fekilde al\u0131nmas\u0131n\u0131n n\u00f6betlerin kontrol alt\u0131na al\u0131nmas\u0131n\u0131 sa\u011flad\u0131\u011f\u0131n\u0131 ve ya\u015fam kalitesini y\u00fckseltti\u011fini s\u00f6yledi.<\/p>\n
\u0130stanbul Atlas \u00dcniversitesi T\u0131p Fak\u00fcltesi N\u00f6roloji Anabilim Dal\u0131 Ba\u015fkan\u0131 Prof. Dr. \u00d6zg\u00fcr Bilgin Top\u00e7uo\u011flu, 9 \u015eubat Uluslararas\u0131 Epilepsi G\u00fcn\u00fc dolay\u0131s\u0131yla yapt\u0131\u011f\u0131 a\u00e7\u0131klamada epilepsi hastalar\u0131nda d\u00fczenli kontrol ve ila\u00e7 kullan\u0131m\u0131n\u0131n \u00f6nemine ili\u015fkin de\u011ferlendirmede bulundu.<\/p>\n
Hastal\u0131\u011f\u0131n seyri ki\u015fiden ki\u015fiye de\u011fi\u015fiyor<\/p>\n
Epilepsi hastal\u0131\u011f\u0131nda d\u00fczenli doktor kontrol\u00fcn\u00fcn \u00f6nemli oldu\u011funu belirten Prof. Dr. \u00d6zg\u00fcr Bilgin Top\u00e7uo\u011flu, \u201cEpilepsi hastalar\u0131nda d\u00fczenli doktor kontrol\u00fc, n\u00f6betlerin kontrol alt\u0131nda tutulmas\u0131, ila\u00e7lar\u0131n etkinli\u011finin ve yan etkilerinin izlenmesi, ya\u015fam kalitesinin art\u0131r\u0131lmas\u0131 a\u00e7\u0131s\u0131ndan kritik \u00f6neme sahiptir. Tedavi s\u00fcreci ki\u015fiye \u00f6zel oldu\u011fu i\u00e7in d\u00fczenli takip, hastal\u0131\u011f\u0131n seyrini do\u011frudan etkiler. Epilepsi hastalar\u0131nda doktor kontrol\u00fc i\u00e7in tek bir standart s\u00fcre yoktur \u00e7\u00fcnk\u00fc bu hastal\u0131\u011f\u0131n seyri ki\u015fiden ki\u015fiye de\u011fi\u015fir\u201d diye konu\u015ftu.\u00a0<\/p>\n
Kontrol d\u00f6nemleri her hasta i\u00e7in farkl\u0131l\u0131k g\u00f6sterebilir<\/p>\n
Doktor kontrol\u00fcn\u00fcn hastal\u0131\u011f\u0131n tan\u0131 ve tedavi s\u00fcre\u00e7lerine g\u00f6re farkl\u0131l\u0131k g\u00f6sterebilece\u011fini ifade eden Prof. Dr. \u00d6zg\u00fcr Bilgin Top\u00e7uo\u011flu, bu d\u00f6nemleri \u015f\u00f6yle s\u0131ralad\u0131:\u00a0<\/p>\n
Tan\u0131 ve tedavi ba\u015flang\u0131c\u0131: \u0130la\u00e7 ba\u015fland\u0131ktan sonra genellikle ilk birka\u00e7 ay i\u00e7inde s\u0131k kontroller yap\u0131l\u0131r. Bu d\u00f6nemde ilac\u0131n etkinli\u011fi ve yan etkileri yak\u0131ndan izlenir.<\/p>\n
Tedavi oturduktan sonra: N\u00f6betler kontrol alt\u0131na al\u0131nd\u0131\u011f\u0131nda kontroller 3\u20136 ayda bir yap\u0131labilir.<\/p>\n
\u0130la\u00e7 de\u011fi\u015fikli\u011fi veya yeni \u015fik\u00e2yetler oldu\u011funda: Daha s\u0131k kontroller gerekebilir.<\/p>\n
\u00c7ocuk ve gen\u00e7 hastalarda: Geli\u015fim ve \u00f6\u011frenme s\u00fcreci izlendi\u011fi i\u00e7in kontroller daha d\u00fczenli ve s\u0131k yap\u0131l\u0131r.<\/p>\n
\u0130la\u00e7 tedavisiyle n\u00f6betlerin s\u0131kl\u0131\u011f\u0131 ve \u015fiddeti azal\u0131r<\/p>\n
Epilepsi tedavisinde en temel y\u00f6ntemin antiepileptik ila\u00e7lar oldu\u011funu kaydeden Prof. Dr. \u00d6zg\u00fcr Bilgin Top\u00e7uo\u011flu, \u201cBu ila\u00e7lar n\u00f6betleri tamamen ortadan kald\u0131rmasa da \u00e7o\u011fu hastada n\u00f6betlerin s\u0131kl\u0131\u011f\u0131n\u0131 ve \u015fiddetini azalt\u0131r. D\u00fczenli ve do\u011fru dozda kullan\u0131ld\u0131\u011f\u0131nda hastalar\u0131n yakla\u015f\u0131k y\u00fczde 70\u201380\u2019inde n\u00f6betler kontrol alt\u0131na al\u0131nabilir. \u0130la\u00e7lar\u0131n aksat\u0131lmas\u0131 n\u00f6betlerin yeniden ba\u015flamas\u0131na, \u015fiddetlenmesine ve ciddi sa\u011fl\u0131k risklerine yol a\u00e7abilir. Epilepsi hastalar\u0131nda ila\u00e7 kullan\u0131m\u0131, tedavinin en kritik par\u00e7as\u0131d\u0131r. \u0130la\u00e7lar\u0131n do\u011fru \u015fekilde al\u0131nmas\u0131 n\u00f6betlerin kontrol alt\u0131na al\u0131nmas\u0131n\u0131 sa\u011flar ve ya\u015fam kalitesini y\u00fckseltir\u201d diye konu\u015ftu.<\/p>\n
\u0130la\u00e7 kullan\u0131m\u0131nda 6 \u00f6nemli nokta!<\/p>\n
\u0130la\u00e7 kullan\u0131m\u0131nda dikkat edilmesi gereken \u00f6nemli noktalara de\u011finen Bilgin Top\u00e7uo\u011flu, bunlar\u0131 \u015f\u00f6yle s\u0131ralad\u0131:<\/p>\n
1. D\u00fczenli ve zaman\u0131nda kullan\u0131m: \u0130la\u00e7lar doktorun belirtti\u011fi saatlerde al\u0131nmal\u0131d\u0131r. Doz atlamak veya ilac\u0131 ge\u00e7 almak, n\u00f6bet riskini art\u0131r\u0131r.<\/p>\n
2. \u0130lac\u0131 kendi kendine b\u0131rakmamak: Antiepileptik ila\u00e7lar ani \u015fekilde kesilmemelidir. Doktor kontrol\u00fc olmadan ila\u00e7 b\u0131rakmak, n\u00f6betlerin \u015fiddetlenmesine ve \u201cstatus epileptikus\u201d gibi hayati risklere yol a\u00e7abilir.<\/p>\n
3. Yan etkileri takip etmek: Ba\u015f d\u00f6nmesi, yorgunluk, kilo de\u011fi\u015fiklikleri gibi yan etkiler g\u00f6r\u00fclebilir. \u015eiddetli yan etkilerde mutlaka doktora ba\u015fvurulmal\u0131d\u0131r.<\/p>\n
4. D\u00fczenli doktor kontrol\u00fc: \u0130la\u00e7lar\u0131n kan d\u00fczeyleri ve organ fonksiyonlar\u0131 (karaci\u011fer, b\u00f6brek) d\u00fczenli testlerle izlenmelidir. Doktor, gerekti\u011finde doz ayarlamas\u0131 veya ila\u00e7 de\u011fi\u015fikli\u011fi yapar.<\/p>\n
5. \u0130la\u00e7 etkile\u015fimlerine dikkat: Baz\u0131 ila\u00e7lar (antibiyotikler, do\u011fum kontrol haplar\u0131 vb.) antiepileptik ila\u00e7larla etkile\u015febilir. Yeni bir ila\u00e7 ba\u015flanmadan \u00f6nce mutlaka doktora dan\u0131\u015f\u0131lmal\u0131d\u0131r.<\/p>\n
6. Ya\u015fam tarz\u0131 ile desteklemek: D\u00fczenli uyku, sa\u011fl\u0131kl\u0131 beslenme ve stres y\u00f6netimi ila\u00e7lar\u0131n etkinli\u011fini art\u0131r\u0131r. Alkol ve uyar\u0131c\u0131 maddelerden uzak durulmal\u0131d\u0131r.<\/p>\n
\u0130la\u00e7lar\u0131n aksat\u0131lmas\u0131 ya da b\u0131rak\u0131lmas\u0131 \u00f6nemli riskler olu\u015fturabilir<\/p>\n
Prof. Dr. \u00d6zg\u00fcr Bilgin Top\u00e7uo\u011flu, doktor \u00f6nerisi olmadan ilac\u0131n b\u0131rak\u0131lmas\u0131 ya da ila\u00e7 dozlar\u0131n\u0131n d\u00fczensiz kullan\u0131m\u0131n\u0131n olumsuz pek \u00e7ok etkiye yol a\u00e7abilece\u011fi uyar\u0131s\u0131nda da bulunarak \u201cAntiepileptik ila\u00e7lar, beynin elektriksel aktivitesini dengelemeye \u00e7al\u0131\u015f\u0131r; bu denge bozuldu\u011funda n\u00f6betler yeniden ortaya \u00e7\u0131kabilir veya \u015fiddetlenebilir. Olas\u0131 etkiler aras\u0131nda n\u00f6betlerin tekrar\u0131 ve \u015fiddetlenmesi, tedaviye diren\u00e7 geli\u015fmesi, yan etkilerin artmas\u0131 ve g\u00fcnl\u00fck ya\u015fam\u0131 etkileyecek \u00f6nemli riskler olu\u015fabilir\u201d uyar\u0131s\u0131nda bulundu.\u00a0<\/p>\n
Oru\u00e7 tutmak isteyen, mutlaka doktoruna dan\u0131\u015fmal\u0131<\/p>\n
Ramazan ay\u0131nda oru\u00e7 tutmak isteyen epilepsi hastalar\u0131n\u0131n mutlaka doktorlar\u0131na dan\u0131\u015fmas\u0131 gerekti\u011fini s\u00f6yleyen Prof. Dr. \u00d6zg\u00fcr Bilgin Top\u00e7uo\u011flu, s\u00f6zlerini \u015f\u00f6yle tamamlad\u0131: \u201cA\u00e7l\u0131k ve susuzluk, kan \u015fekeri d\u00fc\u015f\u00fckl\u00fc\u011f\u00fc ve ila\u00e7lar\u0131n kandaki seviyesinin de\u011fi\u015fmesi, n\u00f6bet riskini art\u0131r\u0131r ve uyku d\u00fczensizli\u011fi, n\u00f6betleri tetikleyebilece\u011fi i\u00e7in oru\u00e7 tutmak isteyen epilepsi hastalar\u0131n\u0131n mutlaka n\u00f6roloji uzman\u0131na dan\u0131\u015fmalar\u0131 gerekir. Epilepsi hastalar\u0131 i\u00e7in oru\u00e7 tutmak ki\u015fisel sa\u011fl\u0131k durumuna ba\u011fl\u0131d\u0131r. Uzun s\u00fcredir n\u00f6bet ge\u00e7irmeyen ve doktor onay\u0131 alan baz\u0131 hastalar oru\u00e7 tutabilir ancak ila\u00e7lar\u0131n d\u00fczenli kullan\u0131m\u0131, uyku ve beslenme d\u00fczeni mutlaka korunmal\u0131d\u0131r.\u201d<\/p>\n
\u00a0<\/p>\n
Kaynak: (BYZHA) Beyaz Haber Ajans\u0131<\/p>\n","protected":false},"excerpt":{"rendered":"
Epilepsi tedavisinde kullan\u0131lan antiepileptik ila\u00e7lar\u0131n \u00e7o\u011funun hastada n\u00f6betlerin s\u0131kl\u0131\u011f\u0131n\u0131 ve \u015fiddetini azaltt\u0131\u011f\u0131n\u0131 belirten \u0130stanbul Atlas \u00dcniversitesi T\u0131p Fak\u00fcltesi N\u00f6roloji Anabilim Dal\u0131 Ba\u015fkan\u0131 Prof. Dr. \u00d6zg\u00fcr Bilgin Top\u00e7uo\u011flu, \u201cD\u00fczenli ve do\u011fru dozda kullan\u0131ld\u0131\u011f\u0131nda hastalar\u0131n yakla\u015f\u0131k y\u00fczde 70\u201380\u2019inde n\u00f6betler kontrol alt\u0131na al\u0131nabilir.<\/p>\n","protected":false},"author":1,"featured_media":19581,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[469,3587,467,660,3588],"class_list":["post-19580","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-bas","tag-duzenli","tag-hasta","tag-ilac","tag-ilaclarin"],"_links":{"self":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/19580","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/comments?post=19580"}],"version-history":[{"count":1,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/19580\/revisions"}],"predecessor-version":[{"id":19582,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/19580\/revisions\/19582"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/media\/19581"}],"wp:attachment":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/media?parent=19580"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/categories?post=19580"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/tags?post=19580"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}